FDA Compliance for Peptide Therapy and BPC 157 Holt Law The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and From 'Wolverine' healing claims to health warnings: The unregulated rise of peptides ABC7 Los Angeles The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and commercialization FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times